Form 4: Politan Capital Exits Masimo Position Following Merger

Politan Capital Management reports the termination of forward sale contracts following the acquisition of Masimo Corporation by Danaher Corporation.

Summary

• Politan Capital Management and associated entities terminated two forward sale contracts involving 273,550 total shares of Masimo Corporation (MASI).
• The termination occurred on June 10, 2026, following the completion of the merger between Masimo and Danaher Corporation.
• Under the merger terms, each outstanding share of Masimo common stock was converted into the right to receive $180.00 in cash.
• Politan Master Fund paid a total of $49,239,000 to the counterparty to settle the forward contracts based on the $180.00 per share merger price.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a neutral-to-positive event for the reporting entity, as it represents the successful conclusion of an investment thesis and the orderly liquidation of a position following a merger.

Positives

• Successful realization of investment value through the acquisition of Masimo by Danaher at $180.00 per share.
• Clear and orderly settlement of derivative obligations following the change in control of the issuer.

Negatives

• The settlement of the forward contracts resulted in a net cash outflow of approximately $1.58 million relative to the initial upfront payments received in March 2026.

Risks

• No ongoing risks as the reporting person no longer holds a beneficial interest in the issuer following the merger completion.

Future Outlook

No future outlook provided as the reporting person has exited their position in the issuer due to the merger.

Management Comments

• The reporting persons disclaim any beneficial ownership of the subject securities, except to the extent of any pecuniary interest therein.

Industry Context

StockSavvy.ai notes that this filing marks the final chapter of Politan Capital's activist campaign at Masimo, concluding with a successful exit via a strategic acquisition by Danaher Corporation, a major player in the life sciences and diagnostics space.

Comparison to Industry Standards

• The $180.00 per share acquisition price represents a standard premium-based exit for activist investors in the medical technology sector.
• The use of forward sale contracts is a common hedging and liquidity management tool utilized by institutional investment firms during M&A events.

Stakeholder Impact

• Shareholders of Masimo received $180.00 per share in cash as part of the merger agreement.

Next Steps

• None; the reporting person no longer holds shares in the issuer.

Key Dates

Keywords

Masimo, MASI, Politan Capital, Merger, Danaher, Form 4, Derivative Securities, Forward Sale Contract